
Gene Therapy Trials for Hemophilia A: Where We Are and What Comes Next
Here’s what we’ll discuss
-
A general overview of the clinical trial process
-
Details on the design of the BioMarin gene therapy clinical trial program for hemophilia A (BMN 270) and its
current progress -
BioMarin's approach to advocacy for the hemophilia community
WATCH THE VIDEO